论文信息 - Liver capsule: Molecular‐based signatures in hepatocellular carcinoma

Liver capsule: Molecular‐based signatures in hepatocellular carcinoma

eren es 1. H ohida Y , V illaueva A , K obyashi M , P ix J, C hang D Y , C am argo A , et l. G ne exession in fi ed tiues nd otcom e in hepcellular cacinom a. N E gl J M ed 2008;31995-2004. 2. ee JS , H eo J, Librecht L, C hu IS , K aosi-N ovak P , C avisi D F , et l. A nvel pronostic sutype of um an hepcellular cacinom a drived fom hpatic proenitor clls. N at M ed 2006:410-416. 3. Z cm an-R ossi J, V illaueva A , N ault JC , Lvet JM , et l. G eetic lanscape nd biom akers of hepcellular cacinom a. G astroterology 201549:1226139.

A. Villanueva | A. Craig

[1] J. Zucman‐Rossi,et al. Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. , 2015, Gastroenterology.

[2] Sandrine Imbeaud,et al. DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma , 2015, Hepatology.

[3] Kenji Ikeda,et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. , 2008, The New England journal of medicine.

[4] Jin Woo Kim,et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. , 2008, Cancer research.

[5] S. Thorgeirsson,et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells , 2006, Nature Medicine.